[ASND] QoQ Quarter Result on 30-Jun-2019 [#Q2]

Stock
[ASND] Ascendis Pharma A/S
Announcement Date
30-May-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- -9.82%
YoY- -158.61%
Quarter Report
ASND's Result
ASND's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Revenue 2,225 2,507 2,243 3,211 5,414 10,515 20 2206.50%
PBT -63,394 -80,400 -25,174 -58,969 -53,707 -32,066 -34,067 51.23%
Tax -77 -38 -61 -65 -70 -88 -100 -15.97%
NP -63,317 -80,362 -25,113 -58,904 -53,637 -31,978 -33,967 51.40%
Tax Rate - - - - - - - -
Total Cost 65,542 82,869 27,356 62,115 59,051 42,493 33,987 54.86%
Ratio Analysis
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
NP Margin -2,845.71 -3,205.50 -1,119.62 -1,834.44 -990.71 -304.12 -169,835.00 -93.43%
Per Share
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
EPS -1.32 -1.68 -0.53 -1.25 -1.24 -0.76 -0.81 38.44%
EPS Diluted -1.32 -1.67 -0.53 -1.25 -1.24 -0.74 -0.81 38.44%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.